TTUHSC Researcher Receives NIH Grant for Vaccine
News Release
FOR IMMEDIATE RELEASE
January 5, 2016
CONTACT: Suzanna Cisneros, suzanna.cisneros@ttuhsc.edu
(806) 743-7605
TTUHSC Researcher Receives NIH Grant for Vaccine
Vaccine Could Impact Millions Across the Globe
Texas Tech University Health Sciences Center (TTUHSC) researcher Afzal A. Siddiqui, Ph.D., a Grover E. Murray Distinguished Professor at the TTUHSC School of Medicine, received a $3.82 million grant from the National Institutes of Health (NIH). The three-year NIAID/SBIR-R44 Phase II Grant is to prepare the Schistosomiasis Vaccine (SchistoShield®) for human clinical trials. This phase of the research funding is in collaboration with Darrick Carter, president and CEO of PAI Life Science in Seattle, WA.
Over 200 million people suffer from the disease in 74 countries and four times that many are at risk since they do not have access to clean water. A recent discovery in Siddiqui’s TTUHSC research laboratory may make it possible to reduce the number of infections from this disease.
According to the World Health Organization, there are no commercially available vaccines against schistosomiasis, which afflicts people primarily in Asia, Africa and South America.
A person gets a schistosoma infection through contact with contaminated water. The
parasite swims freely in open bodies of water. Once contact is made with humans, the
parasite burrows into the skin, matures into another stage, and then migrates to the
lungs and liver, where it matures into the adult form.
“Dr. Siddiqui is the quintessential investigator and has brought distinction not only to this research but to our university,” said TTUHSC President Tedd L. Mitchell, M.D. “We are extremely proud of his work and congratulate him on this NIH grant.”
The vaccine, “SchistoShield®” potentially can impact up to one billion people.
Siddiqui also recently received a U.S. patent for the schistosomiasis vaccine. With
this NIH grant and an ongoing Bill & Melinda Gates Foundation grant, Siddiqui’s research
team has over $7 million in current grant funding and over $11.5 million in total
funding thus far on this project.
-30-
Related Stories
Noise-Induced Hearing Loss in Rural Adolescents
Leigh Ann Reel, Au.D., Ph.D., CCC-A, discussed the causes and prevention strategies for noise-induced hearing loss, particularly for adolescents in rural areas.
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Recent Stories
Texas Tech University Health Sciences Center Earns SACSCOC Recognition
TTUHSC has received a clean bill of health from the regional accrediting body, the Southern Association of Colleges and Schools Commission on Colleges (SACSCOC), following a Fifth-Year Interim Review by a committee from peer institutions.
Noise-Induced Hearing Loss in Rural Adolescents
Leigh Ann Reel, Au.D., Ph.D., CCC-A, discussed the causes and prevention strategies for noise-induced hearing loss, particularly for adolescents in rural areas.
TTUHSC Amarillo Awarded $50,000 Grant for Cutting-Edge Cancer Research
TTUHSC in Amarillo has received a $50,000 grant from the Harrington Cancer and Health Foundation to support groundbreaking cancer research led by Hiranmoy Das, Ph.D.